Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary ...

The Innsbruck Physics Lecture has welcomed many distinguished researchers to Innsbruck, among them several Nobel laureates, ...

Companies exploring automated workflows would be well advised to keep their AI agents on a short leash. Microsoft researchers ...

Scientists at the University of Maryland, Baltimore County, have uncovered a crucial trick used by enteroviruses—the group behind diseases like polio, myocarditis, encephalitis, and even the common ...

Researchers studying the dark proteome are investigating proteins that lack clear structures or known functions. Experts, ...

The registrational intent ACR-368 Phase 2b study is advancing with a prespecified simultaneous interim analysis and data update for both ...

India, May 8 -- Malaria remains one of the world's deadliest infectious diseases, despite being preventable and treatable.

Detailed price information for Acrivon Therapeutics Inc (ACRV-Q) from The Globe and Mail including charting and trades.

In 1982, materials scientist Dan Shechtman observed an unusual tenfold symmetry in an aluminum-manganese alloy, defying the ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 5:20 PM EDTCompany ParticipantsRamy Farid - CEO, President ...

Researchers at the University of Maryland, Baltimore County (UMBC) have uncovered a crucial step that enteroviruses use to reproduce inside human ...